Hub Genes Involved in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma

被引:1
作者
Liu, Baiyi [1 ]
Wang, Xiaoxiao [1 ]
Wu, Nan [1 ]
Liu, Feng [1 ]
Rao, Huiying [1 ]
机构
[1] Peking Univ Peoples Hosp, Peking Univ Hepatol Inst, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing Int Cooperat Base Sci & Technol NAFLD Diag, Beijing, Peoples R China
关键词
Nonalcoholic fatty liver disease (NAFLD); hepatocellular carcinoma (HCC); biomarkers; progression; prognosis; FIBROSIS STAGE; INFLAMMATION; VERSICAN; CELLS; NASH; STEATOHEPATITIS; PREVALENCE; PLATELETS; APOPTOSIS; PROTEIN;
D O I
10.2174/0109298673288887240212065116
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. With an increasing number of patients, NAFLD has been identified as a risk factor for Hepatocellular Carcinoma (HCC). The precise pathophysiology of NAFLD-related HCC has not been completely understood recently.Objective We analyzed the hub genes related to NAFLD and HCC to predict the risk of NAFLD progressing to HCC.Methods Two datasets of NAFLD were used to identify differentially expressed genes. Lasso-Cox regression analysis was performed to determine a gene model to predict the risk of the progression from NAFLD to HCC. Three validation datasets were analyzed to evaluate the performance of the gene model, including normal and NAFLD with fibrosis, NAFLD with fibrosis and NAFLD-related HCC, and normal and NASH-related HCC.Results Seven genes, including COL1A1, TIPM1, VCAN, FOS, CD79A, CXCL9, and VWF, were identified as the hub genes, and then a gene model was constructed. By calculating, the area under the receiver operating characteristic curves (AUCs) for risk prediction were 0.97, 0.886, and 0.751 in the three validation datasets, respectively. Gene set enrichment analysis indicated that the MAPK, TGF beta, p53, PPAR, insulin signaling pathways, and fatty acid metabolism were significantly upregulated in the high-risk group. GTPase activity and intrinsic apoptotic signaling pathway had significant upregulation in the low-risk group.Conclusion The seven hub genes may predict the risk of NAFLD developing into HCC by mediating the potential molecular mechanism, which could be used as biomarkers for predicting the progression, diagnosis, and treatment of NAFLD.
引用
收藏
页数:21
相关论文
共 75 条
  • [1] CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study
    Angeles Jimenez-Sousa, Maria
    Zaida Gomez-Moreno, Ana
    Pineda-Tenor, Daniel
    Maria Medrano, Luz
    Jose Sanchez-Ruano, Juan
    Fernandez-Rodriguez, Amanda
    Artaza-Varasa, Tomas
    Saura-Montalban, Jose
    Vazquez-Moron, Sonia
    Ryan, Pablo
    Resino, Salvador
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2017, 6
  • [2] From NASH to HCC: current concepts and future challenges
    Anstee, Quentin M.
    Reeves, Helen L.
    Kotsiliti, Elena
    Govaere, Olivier
    Heikenwalder, Mathias
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (07) : 411 - 428
  • [3] MiR-4521 plays a tumor repressive role in growth and metastasis of hepatocarcinoma cells by suppressing phosphorylation of FAK/AKT pathway via targeting FAM129A
    Ayesha, Munawar
    Majid, Abbasi
    Zhao, Dongting
    Greenaway, Frederick T.
    Yan, Naimeng
    Liu, Qinlong
    Liu, Shuqing
    Sun, Ming-Zhong
    [J]. JOURNAL OF ADVANCED RESEARCH, 2022, 36 : 147 - 161
  • [4] Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation
    Bakiri, Latifa
    Hamacher, Rainer
    Grana, Osvaldo
    Guio-Carrion, Ana
    Campos-Olivas, Ramon
    Martinez, Lola
    Dienes, Hans P.
    Thomsen, Martin K.
    Hasenfuss, Sebastian C.
    Wagner, Erwin F.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2017, 214 (05) : 1387 - 1409
  • [5] Emergence of highly profibrotic and proinflammatory Lrat+ FbIn2+ HSC subpopulation in alcoholic hepatitis
    Balog, Steven
    Fujiwara, Reika
    Pan, Stephanie Q.
    El-Baradie, Khairat B.
    Choi, Hye Yeon
    Sinha, Sonal
    Yang, Qihong
    Asahina, Kinji
    Chen, Yibu
    Li, Meng
    Salomon, Matthew
    Ng, Stanley W-K
    Tsukamoto, Hidekazu
    [J]. HEPATOLOGY, 2023, 78 (01) : 212 - 224
  • [6] Gene Ontology Consortium: going forward
    Blake, J. A.
    Christie, K. R.
    Dolan, M. E.
    Drabkin, H. J.
    Hill, D. P.
    Ni, L.
    Sitnikov, D.
    Burgess, S.
    Buza, T.
    Gresham, C.
    McCarthy, F.
    Pillai, L.
    Wang, H.
    Carbon, S.
    Dietze, H.
    Lewis, S. E.
    Mungall, C. J.
    Munoz-Torres, M. C.
    Feuermann, M.
    Gaudet, P.
    Basu, S.
    Chisholm, R. L.
    Dodson, R. J.
    Fey, P.
    Mi, H.
    Thomas, P. D.
    Muruganujan, A.
    Poudel, S.
    Hu, J. C.
    Aleksander, S. A.
    McIntosh, B. K.
    Renfro, D. P.
    Siegele, D. A.
    Attrill, H.
    Brown, N. H.
    Tweedie, S.
    Lomax, J.
    Osumi-Sutherland, D.
    Parkinson, H.
    Roncaglia, P.
    Lovering, R. C.
    Talmud, P. J.
    Humphries, S. E.
    Denny, P.
    Campbell, N. H.
    Foulger, R. E.
    Chibucos, M. C.
    Giglio, M. Gwinn
    Chang, H. Y.
    Finn, R.
    [J]. NUCLEIC ACIDS RESEARCH, 2015, 43 (D1) : D1049 - D1056
  • [7] Versican: a novel modulator of hepatic fibrosis
    Bukong, Terence N.
    Maurice, Sean B.
    Chahal, Barinder
    Schaeffer, David F.
    Winwood, Paul J.
    [J]. LABORATORY INVESTIGATION, 2016, 96 (03) : 361 - 374
  • [8] MicroRNA-29c Acting on FOS Plays a Significant Role in Nonalcoholic Steatohepatitis Through the Interleukin-17 Signaling Pathway
    Cai, Chao
    Chen, Da-Zhi
    Tu, Han-Xiao
    Chen, Wen-Kai
    Ge, Li-Chao
    Fu, Tian-Tian
    Tao, Ying
    Ye, Sha-Sha
    Li, Ji
    Lin, Zhuo
    Wang, Xiao-Dong
    Xu, Lan-Man
    Chen, Yong-Ping
    [J]. FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [9] Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
    Castera, Laurent
    Friedrich-Rust, Mireen
    Loomba, Rohit
    [J]. GASTROENTEROLOGY, 2019, 156 (05) : 1264 - +
  • [10] Platelets: No longer bystanders in liver disease
    Chauhan, Abhishek
    Adams, David H.
    Watson, Steve P.
    Lalor, Patricia F.
    [J]. HEPATOLOGY, 2016, 64 (05) : 1774 - 1784